FIELD: pharmaceuticals.
SUBSTANCE: invention relates to pharmaceutical industry, namely to a method for obtaining an agent for blocking experimental parkinsonism. Method for obtaining an agent for blocking experimental parkinsonism comprises the preparation of a homogenized crude biomass of darkling beetles Alphitobius diaperinus bodies, homogenized biomass of darkling beetles Alphitobius diaperinus bodies is further subjected to aqueous extraction in two stages: at the first stage, one part of the darkling beetles Alphitobius diaperinus bodies is filled with distilled water, infused, centrifuged, and the centrate is separated; at the second stage, the resulting precipitate is filled with distilled water, infused, centrifuged, the centrate is separated, the obtained centrates are combined, the combined centrate is passed through a Millipore bacterial filter, and an aqueous extract of the darkling beetles Alphitobius diaperinus bodies is obtained, wherein the extract comprises: uracil, thymine, isoleucine, proline, phenylalanine, eumelanin, and immobilization is carried out by applying the aqueous extract to the ground sterile phyto-carrier until a moisture content of not more than 12 wt% is achieved.
EFFECT: above-described method provides increased effectiveness of the agent.
1 cl, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT CAPABLE OF STIMULATING PROLIFERATION OF CELLS OF MSC CULTURES - MESENCHYMAL STEM CELLS FROM BONE MARROW OF A DONOR AND HEF - HUMAN EMBRYONIC FIBROBLASTS | 2022 |
|
RU2794155C1 |
| AGENT WITH THE ABILITY TO INCREASE LIFESPAN, IMPROVE COGNITIVE PROPERTIES, MOTOR CONTROL AND COORDINATION OF ANIMAL MOVEMENTS | 2022 |
|
RU2801871C1 |
| AGENT FOR TREATMENT AND PREVENTION OF PARKINSON'S DISEASE | 2006 |
|
RU2324492C1 |
| PEPTIDE WITH NEUROPROTECTIVE ACTIVITY ON MODEL OF MFTP-INDUCED PARKINSONISM AND A PHARMACEUTICAL COMPOSITION ON ITS BASIS | 2017 |
|
RU2662429C1 |
| METHOD FOR OBTAINING MELANIN FROM INSECTS | 2021 |
|
RU2772334C1 |
| 2-((1H-1,2,4-TRIAZO-3-YL)THIO)-3-METHYL-6-(PROP-1-EN-2-YL)CYCLOHEX-3-EN-1-OL AS AN ANTIPARKINSONIAN AGENT | 2022 |
|
RU2796729C1 |
| METHOD OF PARKINSON DISEASE TREATMENT | 1994 |
|
RU2057529C1 |
| INJECTABLE DOSAGE FORM FOR TREATMENT OF PARKINSON'S DISEASE, METHOD FOR PREPARING AND USING IT | 2011 |
|
RU2520758C2 |
| COMBINATION OF RILUSOL AND L-DOFA FOR TREATING PARKINSON'S DISEASE | 1999 |
|
RU2225204C2 |
| ANALOGUES OF CYSTAMINE, USED FOR PARKINSON'S DISEASE TREATMENT | 2012 |
|
RU2630583C2 |
